effect of addition of Aspirin in oral cancer survival
- Conditions
- Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Registration Number
- CTRI/2023/05/052737
- Lead Sponsor
- Banaras Hindu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All Histologically proven cases of primary oral cancers.
Stage T1 to T4, N0 to N3, M0 to M1.
Age above 18.
Karnofskyâ?? performance status more than 70, ECOG 0 to 2
Hb above 8.0 gm/dL
Total count above 4000 cu mm
Platelet count above100000
Serum creatinine less than 1.0mg
Liver enzymes up to 1.5 times normal
Bilirubin less 1.0mg
Patients with acid peptic disease
Pregnant and lactating women.
Patients not willing to participate.
Patients with known allergy to NSAID
Patients with Asthma, rhinitis and nasal polyps
Presence of viral fever
Use of any other blood thinner like warfarin, heparin or low molecular weight heparin
bleeding/blood-clotting disorders (such as hemophilia, vitamin K deficiency, low platelet count)
pyruvate kinase or G6PD deficiency
Patients receiving mifepristone, acetazolamide, corticosteroids, dichlorphenamide, methotrexate, valproic acid, herbal medications (such as ginkgo biloba)
Patients with recent history of anti-viral vaccines
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method